Blood tests could reveal secrets of rectal cancer
NCT ID NCT02874885
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at tiny pieces of cancer cells or DNA floating in the blood of people with rectal cancer. Researchers want to see if these markers can help predict how the tumor responds to standard treatment. About 341 participants, including healthy volunteers, will provide blood samples over time. The goal is to better understand rectal cancer, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can precision protons spare rectal cancer patients from harsh side effects?
- Could a single drug replace surgery for rectal cancer?
- Can adding chemo after radiation help older adults with rectal cancer avoid surgery?
- Can a common muscle relaxant make radiation deadlier for rectal cancer?
- Timing of chemo may boost rectal cancer remission
- Immunotherapy combo may boost rectal cancer treatment